JUN 24, 2019 8:27 AM PDT

New Drug Target for Chemically-Induced Parkinson Disease

WRITTEN BY: Nouran Amin

Once upon a time, a compound found in synthetic opioid, MPTP induced the onset of Parkinson's disease. Early studies show that MPTP induces Parkinson disease in rodents and primates. The most recent study indicates that a naturally-occurring enzyme, known as mitochondrial CYP2D6, can metabolize certain compounds into MPTP-like chemicals and trigger Parkinson in mouse studies. Now, researchers are proposing a new treatment for chemically-induced Parkinson via targeting the mitochondrial CYP2D6 enzyme.

PennToday: Findings from Penn Vet suggest a potential new target for treating Parkinson’s, an enzyme that wreaks its damage on dopamine-producing neurons. Credit: PennToday.UPenn.edu

"Over the past two or three decades, researchers have tried inhibiting the process by which they believed MPTP was metabolized, with mixed success," says research leader, Narayan Avadhani. "We believe that mitochondrial CYP2D6 is the more direct drug target, which might prove better in treating idiopathic Parkinson's disease."

Learn more about Parkinson Disease:

Findings of the study were published in the Journal of Biological Chemistry and investigates the mechanism of Parkinson's disease with unknown causes. Current mechanism of action is believed to involve the oxidation of compounds to form MPP+--a toxic metabolite thought to be transferrable to dopamine neurons via dopamine transporter proteins. The process seemed logical since Parkinson disease is characterized by unusually low dopamine levels in the brain.

PennToday: The new model overturns a current paradigm of how chemical insults lead to Parkinson’s disease. (Image: Avadhani lab)

Targeting the mechanism of action, researchers showed that mice lacking CYP2D6 did not present with any severe symptoms that mice with the protein did. Furthermore, a CYP2D6 inhibitor was seen to prevent neuronal damage in mice.

"CYP2D6 is known to play a role in influencing the activity of a number of drugs," says Avadhani. "The CYP2D6 inhibitor ajmalicine is a member of the reserpine family of alkaloids, found in the plant Rauwolfia serpentine and was long used in India for treating mental illness, such as paranoia and schizophrenia. Mitochondrial targeting of such compounds is likely to be effective in treating Parkinson's patients, and pursuing that is our future strategy."

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 08, 2020
Cannabis Sciences
Can Cannabis Treat Epilepsy?
NOV 08, 2020
Can Cannabis Treat Epilepsy?
There has been growing interest in recent years for cannabis to treat central nervous system disorders. And so far, ther ...
NOV 02, 2020
Drug Discovery & Development
Type 2 Diabetic Drug Combo Proves Effective
NOV 02, 2020
Type 2 Diabetic Drug Combo Proves Effective
A common first-line therapeutic for type 2 diabetes is the metformin drug used to stabilize blood glucose levels. Althou ...
NOV 25, 2020
Immunology
The History of Vaccines
NOV 25, 2020
The History of Vaccines
Everyone worldwide is sitting with anticipation, waiting for the right vaccine candidate for the coronavirus outbreak, h ...
NOV 15, 2020
Drug Discovery & Development
Drug Stimulates Female Fertility
NOV 15, 2020
Drug Stimulates Female Fertility
A recent drug, MVT-602, was found to stimulate fertility by acting on the natural 'kisspeptin' hormone system in ...
NOV 09, 2020
Drug Discovery & Development
Can Oxidants Slow Down Cellular Aging?
NOV 09, 2020
Can Oxidants Slow Down Cellular Aging?
Oxidants are reactive oxygen species known to be harmful to living organisms at high concentrations and have been linked ...
DEC 01, 2020
Drug Discovery & Development
Breakthrough Drug Reduces Inflammation and Pain in Arthritis
DEC 01, 2020
Breakthrough Drug Reduces Inflammation and Pain in Arthritis
Researchers from the Universities of Oxford and Birmingham in the UK have found that otilimab can reduce infla ...
Loading Comments...